236 related articles for article (PubMed ID: 15127593)
1. [Research progress on regulation of class II MHC expression].
Sun QH; Peng JP
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):25-9. PubMed ID: 15127593
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of the Bare lymphocyte syndrome.
Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
[TBL] [Abstract][Full Text] [Related]
4. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
[TBL] [Abstract][Full Text] [Related]
5. The bare lymphocyte syndrome and the regulation of MHC expression.
Reith W; Mach B
Annu Rev Immunol; 2001; 19():331-73. PubMed ID: 11244040
[TBL] [Abstract][Full Text] [Related]
6. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.
Waldburger JM; Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Landmann S; Reith W
Immunol Rev; 2000 Dec; 178():148-65. PubMed ID: 11213800
[TBL] [Abstract][Full Text] [Related]
7. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.
Villard J; Lisowska-Grospierre B; van den Elsen P; Fischer A; Reith W; Mach B
N Engl J Med; 1997 Sep; 337(11):748-53. PubMed ID: 9287230
[TBL] [Abstract][Full Text] [Related]
8. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
[TBL] [Abstract][Full Text] [Related]
9. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
[TBL] [Abstract][Full Text] [Related]
11. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
Peijnenburg A; Van Eggermond MJ; Gobin SJ; Van den Berg R; Godthelp BC; Vossen JM; Van den Elsen PJ
J Immunol; 1999 Jul; 163(2):794-801. PubMed ID: 10395672
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
[TBL] [Abstract][Full Text] [Related]
14. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
15. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.
Lochamy J; Rogers EM; Boss JM
Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065
[TBL] [Abstract][Full Text] [Related]
16. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
[TBL] [Abstract][Full Text] [Related]
17. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
Gobin SJ; Peijnenburg A; van Eggermond M; van Zutphen M; van den Berg R; van den Elsen PJ
Immunity; 1998 Oct; 9(4):531-41. PubMed ID: 9806639
[TBL] [Abstract][Full Text] [Related]
18. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
[TBL] [Abstract][Full Text] [Related]
19. MHC class I and II deficiencies.
Hanna S; Etzioni A
J Allergy Clin Immunol; 2014 Aug; 134(2):269-75. PubMed ID: 25001848
[TBL] [Abstract][Full Text] [Related]
20. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]